Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pliant Therapeutics (PLRX)
NASDAQ:PLRX
Holding PLRX?
Track your performance easily
See the Price Targets and Ratings of:
PLRX Analyst Ratings
Strong Buy
9 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
PLRX Stock 12 Month Forecast
Average Price Target
$39.25
▲(191.60% Upside)
| Highest Price Target$45.00 | Average Price Target$39.25 | Lowest Price Target$32.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Leerink Partners
Reiterated
11/18/24
H.C. Wainwright
Reiterated
11/08/24
TD Cowen
Assigned
11/08/24
Canaccord Genuity
Reiterated
11/08/24
Stifel Nicolaus
Reiterated
11/08/24
Needham
Reiterated
11/08/24
Oppenheimer
Reiterated
11/08/24
RBC Capital
Reiterated
11/07/24
Piper Sandler
Assigned
09/17/24
Wells Fargo
Reiterated
08/07/24
Citi
$44
Buy
226.89%
Upside
Reiterated
06/06/24
Citi reiterates Buy Rating on Pliant Therapeutics (PLRX)Citi analyst David Lebowitz reiterated a Buy rating and $44.00 price target on Pliant Therapeutics (NASDAQ: PLRX)
BTIG
$33
Buy
145.17%
Upside
Reiterated
02/28/24
Buy Rating Affirmed for Pliant Therapeutics Amid Promising Drug Pipeline and Financial Stability
Best Analysts Covering Pliant Therapeutics
Which Analyst Should I Follow If I Want to Buy PLRX and Sell After:
1 Month
xxx
Success Rate
8/14 ratings generated profit
Average Return
+2.99%
assigned a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 57.14% of your transactions generating a profit, with an average return of +2.99% per trade.
3 Months
xxx
Success Rate
6/14 ratings generated profit
Average Return
+18.80%
assigned a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 42.86% of your transactions generating a profit, with an average return of +18.80% per trade.
1 Year
2 Years
xxx
Success Rate
5/14 ratings generated profit
Average Return
-2.34%
assigned a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 35.71% of your transactions generating a profit, with an average return of -2.34% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
PLRX Analyst Recommendation Trends
Rating
Jun 24
Jul 24
Aug 24
Sep 24
Nov 24
Strong Buy
19
22
15
17
21
Buy
3
5
3
4
3
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
22
27
18
21
24
Each month's total comprises the sum of three months' worth of ratings.
PLRX Financial Forecast
PLRX Stock Forecast FAQ
What is PLRX’s average 12-month price target, according to analysts?
Based on analyst ratings, Pliant Therapeutics’s 12-month average price target is $39.25.
What is PLRX’s upside potential, based on the analysts’ average price target?
Pliant Therapeutics has 191.60% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is PLRX a Buy, Sell or Hold?
Pliant Therapeutics has a consensus rating of Strong Buy which is based on 9 buy ratings, 0 hold ratings and 0 sell ratings.
What is Pliant Therapeutics’s price target?
The average price target for Pliant Therapeutics is $39.25. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $45.00 ,the lowest forecast is $32.00. The average price target represents 191.60% Increase from the current price of $13.46.
The highest analyst price target is $45.00 ,the lowest forecast is $32.00. The average price target represents 191.60% Increase from the current price of $13.46.
What do analysts say about Pliant Therapeutics?
Pliant Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 9 Wall Streets Analysts.
How can I buy shares of PLRX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.